Skip to main content

A dog trainer had no symptoms. An X-ray found a terminal disease

When Christopher Kennedy went to have an X-ray before a routine surgery, he thought he would be in and out. Then a technician spotted scarring in his lungs. 

Kennedy, 68 at the time, had never noticed any warning signs. He was a retired Air Force technician who exercised regularly and spent his time landscaping his backyard and training Bernese Mountain dogs to be hospital therapy animals. 

After several tests, a pulmonologist gave him an alarming diagnosis: Idiopathic pulmonary fibrosis, or IPF. It’s a type of lung disease with no known cause where scar tissue grows in the lungs and prevents oxygen from reaching the bloodstream, according to Dr. Panagis Galiatsatos, a medical spokesperson for the American Lung Association and pulmonologist at Johns Hopkins, who was not involved in Kennedy’s care. The condition is progressive with a “high mortality rate,” Galiatsatos said. 

At first, Kennedy thought he could “beat” the disease. But as his lung function degraded, he realized that was “baloney.” Medications meant to slow the progressive fibrosis weren’t working, and he was starting to need oxygen in his daily life. Even walking to the kitchen was leaving him winded. In 2024, Cleveland Clinic pulmonologist Dr. Aman Pande confirmed Kennedy’s worst fear: He had less than a year to live.

screenshot-2025-07-24-at-11-11-29-am.png
Christopher Kennedy and his wife on their anniversary in 2021. 

Christopher Kennedy / Cleveland Clinic

“We all wonder, as human beings, how we’re going to go,” Kennedy said. “And you never know. It’s a great mystery. Well, for the first time in my life, I was told ‘This is how you’re going to go.'” 

“You come out one of two ways”    

Pande did have one option for Kennedy: They could see if he was eligible for a double-lung transplant. Kennedy, at 74, was older than most patients who undergo the operation, but he was otherwise a promising candidate, Pande said. Lung transplants are usually the final option offered to IPF patients, Pande said, and are usually curative, though a small percentage of patients can see the condition recur. 

Kennedy was initially resistant to the idea, because his younger brother had died after the same procedure. But after more convincing from Pande, he agreed to undergo testing to see if he would be eligible. Cleveland Clinic doctors “scoured everything,” Kennedy said. Finally, he was approved as a candidate. He was registered on the national transplant list, and waited for a pair of suitable lungs to become available. 

As the months passed, Kennedy’s lung function continued to degrade. He went from using two liters of oxygen a day to 10. He had a mild case of COVID-19. He lost more than 40 pounds. In October 2024, he was admitted to the hospital. 

“Dr. (Jason) Turowski, (a transplant pulmonologist at Cleveland Clinic) said ‘OK, we’re going to admit you and you come out one of two ways: With a set of lungs, or we’re going to carry you out,'” Kennedy recalled. 

fini-visiting-chris-in-hospital.jpg
Bernese Mountain dog Fini visits Christopher Kennedy in the hospital.

Christopher Kennedy / Cleveland Clinic

“You’re reminded every breath matters” 

Kennedy spent a month in the hospital. There were two false alarms, where it seemed that a pair of lungs might be available but ultimately were not. The third time was the charm, and on Nov. 15, Kennedy underwent a double-lung transplant. 

“It was a relief. I was apprehensive, obviously, and anxious. I can remember going into the operating room,” Kennedy said. “I can remember the flurry of activity, all the people that were in there getting me ready for the surgery. Next thing you know, you’re in your room.” 

Just hours after the surgery, Kennedy’s lung capacity was already better than it had been in months. He had several setbacks, including a post-surgery infection and a stroke, but his “indomitable spirit” has helped him recover, said pulmonologist Rachel Powers, who has been part of Kennedy’s post-transplant care team.  

walking-after-transplant.jpg
Christopher Kennedy early in his post-transplant recovery.

Christopher Kennedy / Cleveland Clinic

“I’m very proud of him. He really has kept a very good perspective of his course of recovery,” Powers said. “He’s kept such a good outlook, and I think that’s been really important for some of the things that he’s had to overcome after transplant.” 

For Kennedy, now 75, life is now beginning to feel normal again. Tests show that his lung capacity is at 98%. He is back to spending time with his wife, children and grandkids. He is able to exercise at home and was recently able to take his dog for a walk without losing his breath. He’s almost done training the canine, a Bernese Mountain dog named Fini, to be a hospital therapy dog. 

Kennedy had believed Fini would be the last therapy dog he trained, and named him after the retirement flights conducted by Air Force members. But in a few weeks, he’ll be getting a new puppy. He plans to name her Encore to celebrate his own second chance. Training hospital therapy dogs has become even more meaningful after his own medical journey, he said. 

“There’s a lot of things that are different in my life. It gives you great perspective and proportion of life, of what’s important and what isn’t,” Kennedy said. “You take every breath for granted, because, you know, why would you not? But as soon as they become compromised, you’re reminded every breath matters. It keeps you centered.” 

two-months-before-transplant.jpg
Christopher Kennedy in September 2024.

Christopher Kennedy / Cleveland Clinic

Dr. Erica Schwartz appears before Senate committee for confirmation hearing as next CDC director

President Donald Trump has nominated Dr. Erica Schwartz, to be the Director of the CDC, April 16, 2026. (Department of Health and Human Services)(WASHINGTON) -- A confirmation hearing began on Wednesday for Dr. Erica Schwartz to be the next director of the Centers for Disease Control and Prevention (CDC).Schwartz, a formal deputy surgeon general, was nominated by President Donald Trump in April. Trump made the announcement in a post on Truth Social, describing Schwartz as "incredibly talented."Schwartz is the fourth person named or nominated as head of the CDC since last summer. If confirmed by the Senate, Schwartz will replace Dr. Jay Bhattacharya, director of the National Institutes of Health, who took over as acting CDC director in February.Schwartz earned a medical degree from Brown University and served in the U.S. Navy until 2005.She served in the U.S. Public Health Service Commissioned Corps, as the Coast Guard Chief Medical Officer and as Deputy Surgeon General from 2019 to early 2021, during the first Trump administration."I was very pleased to see Dr. Schwartz nominated to be the next director of the CDC," Dr. Richard Besser, former acting director of the CDC during the Obama administration, told ABC News. "What struck me is how refreshing it felt to see someone nominated for this job who actually has deep experience in public health and has the credentials necessary to lead a complex public health organization."Besser expressed concern about whether Schwartz, if confirmed, will have the independence from Health and Human Services Secretary Robert F. Kennedy Jr. to make public health recommendations, referencing a previous CDC director: Susan Monarez.Monarez was confirmed as CDC director in July 2025, but she held the post for less than a month. Monarez was fired by Kennedy for reportedly not rubber-stamping the health secretary's vaccine agenda or firing high-ranking CDC leaders whom he opposed.The turmoil led to both Kennedy and Monarez appearing in front of Senate committees to address the ousting.At a Senate hearing, Kennedy denied telling Monarez to accept vaccine recommendations without scientific evidence and claimed she was fired in part because she told him she was untrustworthy.Besser said he expects that Schwartz will be asked by members of the Senate Committee on Health, Education, Labor and Pensions (HELP) about her perspectives on vaccinations, the Ebola outbreak in the Democratic Republic of the Congo and the rise of measles in the U.S."Those are some of the critical areas I think she'll be asked about. There are so many other areas that are of concern to those who have relied on the CDC to prevent illness and promote health," he said.Sean Kaufman is also appearing before the Senate HELP Committee for his confirmation hearing on Wednesday. Kaufman was nominated to lead the Administration for Strategic Preparedness and Response, which was recently absorbed under CDC as part of an HHS reorganization in 2025.Kaufman has claimed without evidence that the COVID-19 vaccine caused "excessive death and injury ... in the United States and globally." Health officials have said COVID-19 vaccines are safe and effective following clinical trials that involved tens of thousands of people and have since helped save millions of lives."What concerns me about Mr. Kaufman is that he has expressed very strong anti-vaccine views, and the ASPR is responsible for the strategic national stockpile," Besser said. "So, I hope that the committee asks him questions to fully understand the approach that he would take in that role."Copyright © 2026, ABC Audio. All rights reserved.
Read Next Story